Top news of the week: 18.01.2023.
Angion stock falls after agreeing Elicio Therapeutics merger
Angion Biomedica charts a path forward through reverse merger with clinical-stage biotech Elicio Therapeutics.
The biggest biotech trends that will shape 2023
2023 has begun at full throttle. We collected 7 major biotech trends that industry experts are keeping an eye on over the next 12 months.
AbbVie to Develop mRNA Modulators Using Anima Biotech Platform
AbbVie will discover and develop mRNA biology modulators for three targets in oncology and/or immunology using Anima Biotech’s mRNA Lightning platform, through an up to $582 million ...
Scrip Asks…What Does 2023 Hold For Biopharma? Part 3: Global Headwinds
<p>Headwinds of political instability, violent conflict, inflation and recession accompany us into 2023. <em>Scrip</em> surveyed industry leaders on the impacts for biopharma. </p>
Biopharma Funding Contracted Last Year – And 2023 Will See The Squeeze Continue
<p>Now the pandemic-era biotech boom is over, biopharma companies and investors are both adjusting their financing strategies to survive and even thrive in the new environment.</p>
Leap Jumps Ahead in Cancer Game with Flame Merger
Massachusetts-based biotech Leap Therapeutics announced Tuesday that it had entered into a merger deal with the privately-held Flame Biosciences, Inc.
Biopharma Freelance Opportunities and Where to Find Them
Freelance workers are a significant component of the biopharma industry. Join us as we take a look at a few biopharma freelancing opportunities and learn where to find them.
Beyond Biotech podcast 29: Janssen, Knowledge Gate
This week, our guests are Viktoriya Vasilenko, from Knowledge Gate, and Avery Ince, from Janssen Scientific Affairs.